VOR

Vor Biopharma Inc. is a clinical-stage cell and genome engineering company focused on developing engineered hematopoietic stem cell (eHSC) therapies for cancer patients. The company uses its proprietary platform to enable targeted therapies in combination with stem cell transplants. Vor is working to improve outcomes for patients with blood cancers and solid tumors.